Alrijne Ziekenhuis Leiden Poli Neurologie, t.a.v. C. Holthuijsen
- Address
- Houtlaan 55, 2334 CK Leiden, The Netherlands
Alrijne Ziekenhuis Leiden - Neurology Research Center
Alrijne Ziekenhuis Leiden's Neurology Department is an active clinical research center specializing in progressive neurological disorders, with particular expertise in multiple sclerosis investigation. The center contributes to multicenter studies evaluating innovative therapeutic approaches for challenging neurological conditions.
- Progressive Multiple Sclerosis (PMS) treatment trials
- Advanced neuroimaging analysis including brain atrophy assessment
- Novel immunomodulatory therapeutic agents evaluation
The research team at Alrijne Ziekenhuis demonstrates proficiency in complex quantitative MRI analysis methodologies, including the sophisticated SIENA (Structural Image Evaluation using Normalization of Atrophy) technique for measuring whole brain atrophy. Their participation in placebo-controlled studies reflects commitment to rigorous evidence-based research in neurological diseases, particularly focusing on interventions that may slow disease progression in patients with progressive forms of multiple sclerosis.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Immunic AG1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 271 other sites in The Netherlands
Therapeutic Area Benchmark — The Netherlands
Select a therapeutic area to compare against other sites in The Netherlands.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: The Netherlands
Market Share
Country: The Netherlands
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Alrijne Ziekenhuis Leiden Poli Neurologie, t.a.v. C. Holthuijsen
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy, Safety, and Tolerability of Vidofludimus Calcium in Progressive Multiple Sclerosis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial | Immunic AG | Phase II | Recruiting | Dec 2021 | — |
IMP list
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Vidofludimus Calcium | 1 | Unknown | 2021-12-20 | 2021-12-20 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.